These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 20837337)

  • 21. Ex vivo expansion of umbilical cord blood hemopoietic stem and progenitor cells.
    Wagner JE; Verfaillie CM
    Exp Hematol; 2004 May; 32(5):412-3. PubMed ID: 15145208
    [No Abstract]   [Full Text] [Related]  

  • 22. A novel approach to human leukocyte antigen-mismatched transplantation in patients with malignant hematological disease.
    Huang XJ; Han W; Xu LP; Chen YH; Liu DH; Lu J; Chen H; Zhang YC; Jiang Q; Liu KY; Lu DP
    Chin Med J (Engl); 2004 Dec; 117(12):1778-85. PubMed ID: 15603704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous cord blood transplantation of ex vivo expanded together with non-expanded cells for high risk leukemia.
    Kögler G; Nürnberger W; Fischer J; Niehues T; Somville T; Göbel U; Wernet P
    Bone Marrow Transplant; 1999 Aug; 24(4):397-403. PubMed ID: 10467329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice.
    Gluckman E; Rocha V; Arcese W; Michel G; Sanz G; Chan KW; Takahashi TA; Ortega J; Filipovich A; Locatelli F; Asano S; Fagioli F; Vowels M; Sirvent A; Laporte JP; Tiedemann K; Amadori S; Abecassis M; Bordigoni P; Diez B; Shaw PJ; Vora A; Caniglia M; Garnier F; Ionescu I; Garcia J; Koegler G; Rebulla P; Chevret S;
    Exp Hematol; 2004 Apr; 32(4):397-407. PubMed ID: 15050751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of unrelated cord blood transplants and allogeneic-related hematopoietic stem cell transplants in children with high-risk acute lymphocytic leukemia.
    Jacobsohn DA; Hewlett B; Ranalli M; Seshadri R; Duerst R; Kletzel M
    Bone Marrow Transplant; 2004 Nov; 34(10):901-7. PubMed ID: 15361908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expanding the role of umbilical cord blood transplantation.
    Brunstein CG; Setubal DC; Wagner JE
    Br J Haematol; 2007 Apr; 137(1):20-35. PubMed ID: 17359369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double cord blood transplantation: extending the use of unrelated umbilical cord blood cells for patients with hematological diseases.
    Rocha V; Crotta A; Ruggeri A; Purtill D; Boudjedir K; Herr AL; Ionescu I; Gluckman E;
    Best Pract Res Clin Haematol; 2010 Jun; 23(2):223-9. PubMed ID: 20837334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cord blood transplantation].
    Takahashi S; Asano S
    Gan To Kagaku Ryoho; 2004 Mar; 31(3):307-13. PubMed ID: 15045930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Umbilical cord blood transplantation: pros, cons and beyond.
    Stanevsky A; Goldstein G; Nagler A
    Blood Rev; 2009 Sep; 23(5):199-204. PubMed ID: 19282073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A simplified procedure for hematopoietic stem cell amplification using a serum-free, feeder cell-free culture system.
    Rogers IM; Yamanaka N; Casper RF
    Biol Blood Marrow Transplant; 2008 Aug; 14(8):927-37. PubMed ID: 18640577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New insights into cord blood stem cell transplantation.
    Tse W; Bunting KD; Laughlin MJ
    Curr Opin Hematol; 2008 Jul; 15(4):279-84. PubMed ID: 18536563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
    Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinically relevant expansion of hematopoietic stem cells with conserved function in a single-use, closed-system bioprocess.
    Madlambayan GJ; Rogers I; Purpura KA; Ito C; Yu M; Kirouac D; Casper RF; Zandstra PW
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1020-30. PubMed ID: 17084368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors.
    Laughlin MJ; Barker J; Bambach B; Koc ON; Rizzieri DA; Wagner JE; Gerson SL; Lazarus HM; Cairo M; Stevens CE; Rubinstein P; Kurtzberg J
    N Engl J Med; 2001 Jun; 344(24):1815-22. PubMed ID: 11407342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells.
    Jang YK; Jung DH; Jung MH; Kim DH; Yoo KH; Sung KW; Koo HH; Oh W; Yang YS; Yang SE
    Ann Hematol; 2006 Apr; 85(4):212-25. PubMed ID: 16391912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
    Ogawa H; Ikegame K; Yoshihara S; Kawakami M; Fujioka T; Masuda T; Taniguchi Y; Hasei H; Kaida K; Inoue T; Kim EH; Kawase I
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1073-84. PubMed ID: 17084371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of transplanted dose of CD56+ cells on development of graft-versus-host disease in patients receiving G-CSF-mobilized peripheral blood progenitor cells from HLA-identical sibling donors.
    Yamasaki S; Henzan H; Ohno Y; Yamanaka T; Iino T; Itou Y; Kuroiwa M; Maeda M; Kawano N; Kinukawa N; Miyamoto T; Nagafuji K; Shimoda K; Inaba S; Hayashi S; Taniguchi S; Shibuya T; Gondo H; Otsuka T; Harada M;
    Bone Marrow Transplant; 2003 Sep; 32(5):505-10. PubMed ID: 12942097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients.
    Lazarus HM; Koc ON; Devine SM; Curtin P; Maziarz RT; Holland HK; Shpall EJ; McCarthy P; Atkinson K; Cooper BW; Gerson SL; Laughlin MJ; Loberiza FR; Moseley AB; Bacigalupo A
    Biol Blood Marrow Transplant; 2005 May; 11(5):389-98. PubMed ID: 15846293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD34, CD4, and CD8 cell doses do not influence engraftment, graft-versus-host disease, or survival following myeloablative human leukocyte antigen-identical peripheral blood allografting for hematologic malignancies.
    Cao TM; Wong RM; Sheehan K; Laport GG; Stockerl-Goldstein KE; Johnston LJ; Shizuru JA; Negrin RS; Lowsky R
    Exp Hematol; 2005 Mar; 33(3):279-85. PubMed ID: 15730851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.